By Associate Professor Christopher Steer

Conference Abstracts

Kim JH; Cosman R; Steer C; Lee J; Kim JH; Rha SY; Im S-A; Park YH; Jung KH; Zhang SY, 2026, 'Phase Ia study of VRN101099, a brain-penetrant, highly selective covalent HER2 inhibitor, in HER2-positive or HER2-mutant advanced solid tumors.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 44, pp. 1048 - 1048, http://dx.doi.org/10.1200/jco.2026.44.16_suppl.1048

Park J-Y; Yoo J; Cosman R; Kim JH; Steer C; Lee J; Park YH; Im S-A; Rha SY; Kim JH; Jung KH, 2026, 'Abstract LB365: Mechanistic and early clinical characterization of VRN101099, a selective HER2 inhibitor with receptor degradation activity', in Cancer Research, American Association for Cancer Research (AACR), Vol. 86, pp. lb365 - lb365, http://dx.doi.org/10.1158/1538-7445.am2026-lb365

Chilko N; Estacio O; Steer C; Clarke K; Eek R; McBurnie J; Thomas D; Underhill C, 2026, 'The Utility of Molecular Tumor Profiling for Patients With Advanced or Rare Cancer in a Regional Australian Setting', in Asia Pacific Journal of Clinical Oncology, http://dx.doi.org/10.1111/ajco.70059

Uccellini A; O'Haire S; Weickhardt A; Shapiro J; Azad A; Oliveira N; Brown S; Liow E; Steer C; Torres J; Joshua A; Parente P; Goh JC; Smith A; Wong S; Mallesara G; Moujaber T; Inderjeeth A-J; Gibbs P; Tran B; Anton A, 2026, 'Real-world patterns of molecular testing in Australian patients with metastatic CRPC (mCRPC)', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 22, pp. S90 - S90

Dean A; Harris MT; Sjoquist K; Gebski V; Karapetis CS; Lomma C; Burge M; Steer C; Tebbutt N; Lee B; Jackson C; Day F; Padinharakam S; Murray J; Buck KK; Mumford JV; Siu D; Lee J; Gao YR; Price TJ, 2025, '2219P AGITG ASCEND: Randomised, double-blind phase II trial of certepetide (CERT) or placebo (PLA) with gemcitabine (Gem) + nab-paclitaxel (Nab) in patients with untreated metastatic pancreatic ductal adenocarcinoma (mPDAC): Updated results including planned pooled placebo analysis', in Annals of Oncology, Elsevier, Vol. 36, pp. s1233 - s1234, http://dx.doi.org/10.1016/j.annonc.2025.08.2836

Bentick G; Balasubramanian A; Anton A; Azad A; Brown S; Goh JCH; Wong SSL; Parente P; Shapiro J; Liow ECH; Torres J; Smith A; Steer C; Warren M; Gibbs P; Tran B; Weickhardt AJ, 2024, 'Clinicopathological predictors of favourable response to docetaxel in patients with metastatic castration-resistant prostate cancer', in ANNALS OF ONCOLOGY, ELSEVIER, SINGAPORE, Singapore, Vol. 35, presented at European-Society-for-Medical-Oncology Asia Congress (ESMO), SINGAPORE, Singapore, 06 December 2024 - 08 December 2024, http://dx.doi.org/10.1016/j.annonc.2024.10.385

Sivakumaran T; White M; Prall O; Mitchell C; Dijkstra C; Rebello R; Xu H; Vissers J; Grimmond S; Wong H-L; DeFazio A; Gao B; Singh MS; Collins IM; Steer CB; Warren MA; Karanth NV; Bowtell D; Tothill RW; Mileshkin LR, 2024, 'Clinical impact of molecular profiling in the national prospective cohort Solving Unknown Primary Cancer (SUPER) study', in JOURNAL OF CLINICAL ONCOLOGY, LIPPINCOTT WILLIAMS & WILKINS, ELECTR NETWORK, Vol. 42, presented at Special Clinical Science Symposia, ELECTR NETWORK, 29 May 2024 - 29 May 2024

Burge ME; Espinoza D; Sjoquist KM; Siu DHW; Mercieca-Bebber R; Chantrill LA; Karapetis CS; Steer CB; Yip S; Cuff J; Winata S; Tie J; Thaker DA; Tebbutt NC, 2024, 'AGITG MONARCC: A randomized phase 2 study of panitumumab monotherapy and panitumumab (pan) plus 5 fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer—A trial by the Australasian Gastro-Intestinal Trials Group (AGITG).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 42, pp. 3535 - 3535, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.3535

Long D; Collins I; Harris S; Torres J; Faisal W; Wong V; Campbell D; Lankovic K; Wright T; Rachakonda K; Gibbs P; Krishnasamy M; Philip J; Klein O; Blackberry I; Steer C; Underhill C; Lewin T; Duncan J; Green M; Ferres M; Wilkins K, 2024, 'Cancer of Unknown Primary-Shining light into the unknown', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 20, pp. 108 - 109

Kinnane N; Devereux C; Baden P; Dolling M; Steer C; Khot A; Milne D; Wilkinson A; Joyce T; Gyorki D; Heriot A; Krishnasamy M, 2024, 'This is Me: Revision of a co-designed resource to communicate what matters most to older adults with cancer when treatment decisions are being considered', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 20, pp. 214 - 215

Blackberry I; Rasekaba T; Rich S; Webb N; Boak J; Raesima M; Brereton D; Steer C, 2024, 'Working towards equitable age-friendly care among older adults in regional cancer care', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 20, pp. 109 - 109

Long D; Collins IM; Harris S; Torres J; Faisal W; Wong V; Campbell D; Lankovic K; Wright T; Rachakonda K; Gibbs P; Krishnasamy M; Philip J; Klein O; Blackberry I; Steer C; Underhill CR, 2022, 'Regional Victorian trials alliance: Linkages, Innovation, Special populations, Equity (ReViTALISE) project: Addressing disparity in regional populations', in Asia Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 87 - 87, presented at COSA's 49th Annual Scientific Meeting, 02 November 2022 - 04 November 2022, https://onlinelibrary.wiley.com/doi/10.1111/ajco.13868

Schofield P; Ugalde A; Tothill R; Quinn S; Wong HL; Prall O; Mitchell C; Wickramasinghe N; Fedele C; Gordon L; McLean S; Bryant C; Ko H; Akhurst T; Wood C; Yip D; Steer C; Gao B; Wilcken N; Karanth N; Kuchel A; Karapetis CS; Nott L; Padinharakam S; Collins IM; Singh M; Shackleton M; Warren M; Wong R; Wong ZW; Richards N; Todio E; Butler A; Sivakumaran T; Mileshkin L, 2022, 'Solving unknown primary cancer - Earlier diagnosis (SUPER-ED): A stepped wedge cluster randomised controlled trial implementing a Model of Care to support earlier diagnosis', in Asia Pacific Journal of Clinical Oncology, Wiley, Vol. 18, pp. 143 - 144, presented at COSA's 49th Annual Scientific Meeting, 02 November 2022 - 04 November 2022, https://onlinelibrary.wiley.com/doi/10.1111/ajco.13869

Estacio O; Chilko N; Steer C; Underhill C; Clarke K; McBurnie J; Eek R, 2022, 'Changing landscape of lung cancer survival in a regional Australian centre', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 160 - 160

Steer CB; Jayasuriya D; Webb N; Rasekaba T; Young K; Kapur M; Rich S; Blackberry I, 2022, 'Geriatric assessment (GA) in the instagram era: Adding photographs to electronic ga to enhance supportive care (ESC) of older adults with cancer', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 224 - 224

Steer C, 2022, 'Stigma and ageism - The challenges of delivering appropriate care to older adults with NSCLC', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 18, pp. 105 - 105

Weppler AM; Da Meda L; Silva I; Xu W; Grignani G; Menzies AM; Carlino MS; Long GV; Nordman I; Steer C; Lyle M; Trojaniello C; Ascierto PA; Lebbe C; Sandhu SK, 2021, 'Durability of response to immune checkpoint inhibitors (ICI) in metastatic Merkel cell carcinoma (mMCC) after treatment cessation.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 39, pp. 9543 - 9543, http://dx.doi.org/10.1200/jco.2021.39.15_suppl.9543

Friedlander M; Benson C; O'Connell RL; Reed N; Clamp A; Lord R; Millan D; Nottley S; Amant F; Steer C; Anand A; Mileshkin L; Beale P; Banerjee S; Bradshaw N; Kelly C; Carty K; Divers L; Alexander L; Edmondson R, 2021, 'Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903)', in Gynecologic Oncology, Vol. 161, pp. 160 - 165, http://dx.doi.org/10.1016/j.ygyno.2021.02.016

Tebbutt NC; Steer CB; Sjoquist KM; Chantrill LA; Karapetis CS; Nott LM; Espinoza D; Oostendorp M; Yip S; Cuff J; Burge ME, 2020, 'MONARCC: A randomized phase II study of panitumumab monotherapy and panitumumab (pan) plus 5 Fluorouracil (FU) as first-line therapy for RAS and BRAF wild type metastatic colorectal cancer (mCRC): An AGITG clinical trial', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, CA, San Francisco, Vol. 38, presented at Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology, CA, San Francisco, 23 January 2020 - 25 January 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530922700257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Elbourne H; O'Reilly V; Soo K; Norden M; Moran A; Steer C, 2019, 'Exercise and androgen deprivation therapy: Current practice and future direction at a regional cancer centre', in Asia Pacific Journal of Clinical Oncology, Wiley, Adelaide, pp. 198 - 198, presented at 2019 COSA 46th Annual Scientific Meeting, Adelaide, 12 November 2019 - 14 November 2019, http://dx.doi.org/10.1111/ajco.13263

Mileshkin LR; Sivakumaran T; Etemadmoghadam D; Tothill R; Fellowes A; Fox SB; Guccione L; Freimund AE; deFazio A; Wilcken N; Gao B; Singh MS; Collins IM; Richardson GE; Steer CB; Warren MA; Karapetis CS; Bryant C; Schofield P; Bowtell D, 2019, 'Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 37, pp. 3072 - 3072, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3072

Steer C, 2017, 'INCORPORATING GERI-ONCOLOGY ASSESSMENTS IN GU RESEARCH', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, Vol. 13, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000427541700040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page